National Collaborative Innovation Center for Biotherapy
生物治疗协同创新中心

China

1 October 2019 - 30 September 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for National Collaborative Innovation Center for Biotherapy published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: National Collaborative Innovation Center for Biotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
7 1.85

Outputs by subject (Share)

Subject Count Share
Life Sciences 6 1.79
Chemistry 1 0.06

1 October 2019 - 30 September 2020

International vs. domestic collaboration by Share

  • 74.96% Domestic
  • 25.04% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (21 total)

  • National Collaborative Innovation Center for Biotherapy, China
  • Domestic institution
  1. Chinese Academy of Sciences (CAS), China (1.27)
    0.58
    0.69
  2. Beijing Advanced Innovation Center for Structural Biology (ICSB-BJ), China (0.67)
    0.33
    0.33
  3. Geneplus-Beijing Institute, China (0.64)
    0.51
    0.13
  4. Chengdu MedGenCell Co., Ltd., China (0.59)
    0.51
    0.08
  5. Fudan University, China (0.59)
    0.53
    0.06
  6. Southwest Medical University (SWMU), China (0.58)
    0.42
    0.17
  7. ZenRhyme Consulting Service, Ltd., China (0.57)
    0.51
    0.05
  8. Berry Oncology Co., Ltd., China (0.54)
    0.51
    0.03
  9. The Chinese University of Hong Kong (CUHK), China (0.54)
    0.51
    0.03
  10. Shanghai Jiao Tong University (SJTU), China (0.53)
    0.51
    0.02

Top 10 international collaborators by Share (16 total)

  • National Collaborative Innovation Center for Biotherapy, China
  • Foreign institution
  1. University of Pennsylvania (Penn), United States of America (USA) (0.82)
    0.03
    0.79
  2. Penn Medicine, United States of America (USA) (0.76)
    0.03
    0.74
  3. Albert Einstein College of Medicine (Einstein), United States of America (USA) (0.53)
    0.51
    0.01
  4. NYC Health and Hospitals, United States of America (USA) (0.53)
    0.51
    0.01
  5. Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland (0.38)
    0.02
    0.36
  6. Children's National Health System, United States of America (USA) (0.21)
    0.03
    0.18
  7. University of Birmingham (UB), United Kingdom (UK) (0.13)
    0.02
    0.11
  8. University of Oulu, Finland (0.09)
    0.02
    0.07
  9. Seoul National University (SNU), South Korea (0.09)
    0.02
    0.07
  10. MRC/Arthritis Research UK Centre for Musculoskeletal Ageing Research (CMAR), United Kingdom (UK) (0.09)
    0.02
    0.07

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

National Collaborative Innovation Center for Biotherapy

Participating institutions

National Collaborative Innovation Center for Biotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER